← FDA Drug Approvals (Drugs@FDA)

ESCITALOPRAM OXALATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2013-06-12

Drug application

FDA Application #

ANDA090477

Application type

Abbreviated New Drug Application (Generic)

Brand name

ESCITALOPRAM OXALATE

Generic name

ESCITALOPRAM ORAL

Active ingredients

ESCITALOPRAM OXALATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell RX, LLC

First approval

2013-06-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown